Judging New Markers by Their Ability to Improve Predictive Accuracy
Open Access
- 7 May 2003
- journal article
- research article
- Published by Oxford University Press (OUP) in JNCI Journal of the National Cancer Institute
- Vol. 95 (9), 634-635
- https://doi.org/10.1093/jnci/95.9.634
Abstract
The man who has recently received a radical prostatectomy to treat his clinically localized prostate cancer now faces an important decision: whether or not adjuvant therapy would be beneficial. Clearly, a major factor in this decision is the likelihood of his disease recurring in the absence of additional therapy. There are at least three well-documented prognostic models for use in this setting, and each predicts the likelihood of biochemical progression (i.e., prostate-specific antigen [PSA]-defined recurrence of prostate cancer). Partin et al. (1) developed an equation they called “Rw”; Blute et al. (2) devised the “GPSM” score (which includes the Gleason score, PSA level, seminal vesicle status, and margin status), and Kattan et al. (3) derived a postoperative nomogram, which was later validated by Graefen et al. (4). Which of these models predicts best for the individual patient? The GPSM score and the postoperative nomogram have been evaluated by the concordance index and have values of 0.76 and 0.80, respectively, suggesting relatively similar performance. The concordance index is the probability that, given two randomly selected patients, the patient with the worse outcome is, in fact, predicted to have a worse outcome (5). This measure, similar to an area under the receiver operating characteristic curve, ranges from 0.5 (i.e., chance or a coin flip) to 1.0 (perfect ability to rank patients).Keywords
This publication has 8 references indexed in Scilit:
- Multiplex Biomarker Approach for Determining Risk of Prostate-Specific Antigen-Defined Recurrence of Prostate CancerJNCI Journal of the National Cancer Institute, 2003
- Prediction of Progression: Nomograms of Clinical UtilityClinical Prostate Cancer, 2002
- Validation Study of the Accuracy of a Postoperative Nomogram for Recurrence After Radical Prostatectomy for Localized Prostate CancerJournal of Clinical Oncology, 2002
- USE OF GLEASON SCORE, PROSTATE SPECIFIC ANTIGEN, SEMINAL VESICLE AND MARGIN STATUS TO PREDICT BIOCHEMICAL FAILURE AFTER RADICAL PROSTATECTOMYJournal of Urology, 2001
- Comparing tumour staging and grading systems: a case study and a review of the issues, using thymoma as a modelStatistics in Medicine, 2000
- Postoperative Nomogram for Disease Recurrence After Radical Prostatectomy for Prostate CancerJournal of Clinical Oncology, 1999
- MULTIVARIABLE PROGNOSTIC MODELS: ISSUES IN DEVELOPING MODELS, EVALUATING ASSUMPTIONS AND ADEQUACY, AND MEASURING AND REDUCING ERRORSStatistics in Medicine, 1996
- Selection of men at high risk for disease recurrence for experimental adjuvant therapy following radical prostatectomyUrology, 1995